I’m in London, and I just paid for this damn fat drug I take. I said, it’s not working. They said, he said, I just paid $88 ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

Attendees might be looking to wean off weight-loss drugs or mitigate side effects such as digestive discomfort and muscle ...

Ozempic and Mounjaro may also lower your risk of obesity-linked cancer. A study found another potential benefit of the weight loss drugs: lowered risk of chronic conditions.

Bank of Japan to consider slower bond taper as fresh global risks emerge. The central bank’s policy normalisation is at a crossroads as steep US tariffs hurt Japan’s export-heavy economy, forcing the ...

Weight loss drugs, including Wegovy (semaglutide) and Mounjaro (tirzepatide), are becoming increasingly popular among those trying to lose weight. But a rise in so-called "Ozempic babies" has led ...

I lost 7st but online trolls said my 'Mounjaro face' made me look 15 years older Ashley Nickson, 35, tipped the scales at 17st 10lbs and a size 18 to 20 after piling on the weight after giving ...

Mounjaro is a prescription drug used to help manage blood sugar levels in people with type 2 diabetes. It can cause constipation as a side effect. Learn about how to manage this side effect and more.

Mounjaro is a prescription drug taken for type 2 diabetes, and it may be prescribed off-label for weight loss. The Food and Drug Administration (FDA) announced that all doses of tirzepatide, the ...

Mumbai: Sales of Mounjaro, Eli Lilly’s blockbuster weight-loss and diabetes drug, have touched Rs 24 crore within three months of its India launch, making it one of the most popular and fastest ...

Mounjaro can cause constipation due to slowed gastrointestinal movement and changes in appetite or diet as people eat less. Staying hydrated and increasing dietary fiber can help manage this. 5. Loss ...

Lilly's obesity drug Mounjaro's sales rise 60% in India amid rising demand The US drugmaker sold ₹12.6 crore ($1.5 million) worth of the injections last month, according to market analysis firm ...